In other tumors treated with platinum-based chemotherapy, such as ovarian cancer, malignant mesothelioma, or advanced squamous cell carcinoma of the head and neck, association of the ERCC1 8092Ala allele with poor survival has been consistently reported [16], [17], [18]. This evidence concerns the gene ERCC1 and ovarian cancer.